What is the strategy adopted by Lupin in the midst of the COVID wave?
Answer
Answer
Lupin may have missed the start of the COVID race but it is acquiring licences and partnerships for various COVID-19 drugs and vaccines and partnerships with Pfizer and Moderna for COVID-19 vaccines. It plans to license mRNA jabs from Pfizer and Moderna. Lupin saw North America sales slide by 5% yoy but albuterol sales were sharply up. The US is 40% of Lupin sales, but Lupin needs to move quickly on COVID front.